Development of Contents for KFDA Drug Safety Information Website

식품의약품안전청의 의약품안전사용정보방 웹사이트 구축을 위한 컨텐츠 개발

  • Received : 2011.11.21
  • Accepted : 2012.06.26
  • Published : 2012.06.30

Abstract

The purpose of this study was to construct database for a drug safety information website to serve as an access point of up-to-date resources for a wide variety of drug-safety information helping patients and healthcare professionals make well-informed decisions about medication use. All the contents developed were confirmed by the council of advisors who were the experts in drug safety. The detailed contents of database on frequently prescribed drug including 9 NSAIDs, 19 antibiotics, 24 cardiovascular, 21 metabolic, 14 respiratory, 20 digestive, 22 hormonal, 10 genitourinary, 10 anti-allergic, 27 antifungal/antiviral, and 71 neuropsychiatric agents were developed based on the approved drug labeling of the Korean FDA. A separately searchable database of drug-specific safety information for patients and health professionals was constructed for users in need of different depth of knowledge on using medications safely. The safety information on highly prevalent chronic diseases and drug classes was also developed. Finally the most recent global drug safety news was provided. The consumer directed information was developed in layman's terms as means of proving user-friendly information. The creation of this type of website is part of the Korean FDA's ongoing initiative to address and promote the safe use of medications for the public.

Keywords

References

  1. U.S. Food and Drug Administration. Postmarket Drug Safety Information for Patients and Providers. www.fda.gov/cder/ drugsafety.htm (Last accessed on November 14, 2011).
  2. Boyer, E. W., Shannon, M. and Hibberd, P. L. : Web sites with misinformation about illicit drugs. N. Engl. J. Med. 345, 469 (2001).
  3. Health Canada, Canada: MedEffect Canada. Available at www.healthcanada.gc.ca/medeffect (Last accessed on November 14, 2011).
  4. Medicines and Healthcare products Regulatory Agency (MHRA): Safety information. Available at http://www.mhra. gov.uk/Safetyinformation/ (Last accessed on November 14, 2011).
  5. European Medicines Agency (EMA): EMA homepage. Available at http://www.ema.europa.eu/ (Last accessed on November 14, 2011).
  6. 보건복지부, 한국보건복지정보개발원: G-health. Available at http://phi.mw.go.kr/ (Last accessed on November 14, 2011).
  7. 한국건강증진재단: 건강길라잡이. Available at http://www.hp.go.kr/(Last accessed on November 14, 2011).
  8. KFDA: ezDrug. Available at http://ezdrug.kfda.go.kr/ (Last accessed on November 10, 2011).
  9. BlackBox RX, LLC: BlackBoxRx.com homepage. Available at http://blackboxrx.com/ (Last accessed on November 10, 2011).
  10. U.S. Food and Drug Administration: Drug Safety and Availability. Available at http://www.fda.gov/Drugs/DrugSafety/ (Last accessed on November 14, 2011).
  11. U.S. Food and Drug Administration: Index to Drug-Specific Information. Available at http://www.fda.gov/Drugs/Drug Safety/PostmarketDrugSafetyInformationforPatientsand Providers/ucm111085.htm (Last accessed on November 14, 2011).
  12. 식품의약품안전청: 뉴스/소식, 해명u설명u참고자료. Available at http://www.kfda.go.kr/index.kfda?mid=57 (Last accessed on November 10, 2011).
  13. WHO Collaborating Centre for Drug Statistics methodology: WHO Collaborating Centre for Drug Statistics methodology homepage. Available at http://www.whocc.no/ (Last accessed on November 10, 2011).
  14. Dipiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G. and Posey, L. M. eds.: Pharmacotherapy: A Pathophysiologic Approach, 7th ed. McGraw-Hill Companies, Inc. (2008).
  15. Koda-Kimble, M. A., Young, L. Y., Kradjan, W. A., Guglielmo, B. J., Alldredge, B. K., Corelli, R. L. and Williams, B. R. eds.: Applied Therapeutics: The clinical use of drugs, 9th ed. Baltimore, MA: Lippincott Williams & Wilkins (2009).
  16. 식품의약품안전청.고시 제 2010-90호, 의약품 표시기재 지침 전부개정고시 [별표 1] 쉬운 용어 목록(제5조 관련) (2010).
  17. (사)대한약학회 약학용어위원회: 약학용어집. 신일북스 (2008).
  18. 대한의사협회 : 영한u한영 의학용어집. 도서출판 아카데미아(2003).
  19. Park, M. Y. : KMLE 의학 검색 엔진. Available at http://www.kmle.co.kr/ (Last accessed on November 10, 2011).
  20. American Pharmacists Association: Drug Information Handbook, 19th ed. Hudson, OH: Lexi-Comp. (2010).
  21. Thomson Reuters: MicromedexR 2.0. Available at http://www.thomsonhc.com/ (Last accessed on November 10, 2011).
  22. 식품의약품안전청. 공고 제 2008-272호, '임부금기' 의약품공고(2008).
  23. 식품의약품안전청. 임부에 대한 의약품 적정사용 정보집(전문가용)(2010).
  24. Facts & Comparisons: Drug Facts and Comparisons, 63rd ed. Baltimore, MA: Lippincott Williams & Wilkins (2008).
  25. Beers, M. H. : The Merck Manual of Medical Information, 2nd ed. West Point, PA: Merck & Co., Inc. (2003).
  26. U.S. National Library of Medicine: Pubmed.gov. Available at http://www.ncbi.nlm.nih.gov/sites/entrez (Last accessed on November 10, 2011).
  27. U.S. National Library of Medicine: MedlinePlusR. Available at http://www.nlm.nih.gov/medlineplus/ (Last accessed on November 10, 2011).
  28. Centers for Disease Control and Prevention: Centers for Disease Control and Prevention homepage. Available at http://www.cdc.gov/ (Last accessed on November 10, 2011).
  29. Mayo Foundation for Medical Education and Research: Mayo Clinic. Available at http://www.mayo.edu/ (Last accessed on November 10, 2011).